Fortress Biotech (FBIO) Other financing activities (2012 - 2025)
Fortress Biotech (FBIO) posted quarterly Other financing activities of $368000.0 for Q4 2025, up 143.71% year-over-year from $151000.0 in Q4 2024, and down 78.17% quarter-over-quarter from $1.7 million in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Other financing activities (2012 - 2025) Analysis & Trends
Fortress Biotech's Other financing activities history runs 13 years deep, the most recent figure standing at $368000.0 for Q4 2025.
- In Q4 2025, Other financing activities rose 143.71% year-over-year to $368000.0; the TTM figure through Dec 2025 stood at $2.6 million (up 1362.43% YoY), while the FY2025 annual figure was $2.6 million, up 1362.43% from the prior year.
- Other financing activities for Q4 2025 stood at $368000.0, down from $1.7 million in the prior quarter.
- The five-year high for Other financing activities was $36.0 million in Q1 2025, with the low at -$35.4 million in Q2 2025.
- The 5-year median for Other financing activities is $146000.0 (2021), against an average of $338900.0.
- The sharpest annual moves came in 2022 and 2025: Other financing activities slumped 170.21% in 2022, then surged 119900.0% in 2025.
- Fortress Biotech's Other financing activities stood at $141000.0 in 2021, then sank by 170.21% to -$99000.0 in 2022, then jumped by 485.86% to $382000.0 in 2023, then sank by 60.47% to $151000.0 in 2024, then jumped by 143.71% to $368000.0 in 2025.
- Business Quant data shows FBIO's Other financing activities at $368000.0 in Q4 2025, $1.7 million in Q3 2025, and -$35.4 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 368,000.00 |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | -35.41 Mn |
| Mar 31, 2025 | 36.00 Mn |
| Dec 31, 2024 | 151,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 382,000.00 |
| Dec 31, 2022 | -99,000.00 |
| Dec 31, 2021 | 141,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 7,000.00 |
| Dec 31, 2020 | 163,000.00 |
| Jun 30, 2020 | 77,000.00 |
| Mar 31, 2020 | 13,000.00 |
| Dec 31, 2019 | -66.50 Mn |
| Jun 30, 2019 | 31.62 Mn |
| Mar 31, 2019 | 35.00 Mn |
| Mar 31, 2018 | 23.01 Mn |
| Dec 31, 2017 | -8.92 Mn |
| Sep 30, 2017 | 900,000.00 |